Daniel Crona, Pharm.D., Ph.D.

Assistant Professor

Daniel Crona, Pharm.D., Ph.D., joined the UNC Eshelman School of Pharmacy in 2015 as an assistant professor after completing the UNC/Duke/Hamner Institute collaborative postdoctoral fellowship in clinical pharmacology, under the tutelage of Federico Innocenti, M.D., Ph.D., and Howard McLeod, Pharm.D.

Crona received his B.S. from the University of Colorado-Denver in 2006 where he majored in Biology. During this time, he worked as a research associate at the University of Colorado Center for Genetic Lung Disease under James West, Ph.D. on projects related to idiopathic pulmonary hypertension. In 2010, he received his Pharm.D. from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, where he worked with Robert MacLaren, Pharm.D., on a translational research project that focused on gastric motility in critically ill patients.

In 2015, Crona received his Ph.D. from the UNC Eshelman School of Pharmacy, where he worked under the direction of Federico Innocenti, M.D., Ph.D. on a project that identified and validated novel germline genetic variants that associated with survival in patients with advanced or metastatic kidney cancer who received the oral chemotherapeutic agent sorafenib.

Crona is faculty in the Division of Pharmacotherapy and Experimental Therapeutics, in the UNC Center for Pharmacogenomics and Individualized Therapy, and holds a joint appointment as a Clinical Pharmacist Specialist at the University of North Carolina Lineberger Comprehensive Cancer Center. His translational research program will focus on how genetic variations can lead to differences in the pharmacokinetics and pharmacodynamics of therapeutic treatments used in oncology, and how interindividual differences in clinical pharmacology measures can affect survival and drug toxicity phenotypes. He is particularly interested in tyrosine kinase inhibitors, antibody drug conjugates and immunotherapies. His clinical practice focuses on patients with genitourinary malignancies.

  • Post-Doctoral Fellowship, UNC/Duke T32/Hamner Institute Clinical Pharmacology Program
  • Ph.D., University of North Carolina Eshelman School of Pharmacy
  • Pharm.D., University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
  • B.S., University of Colorado- Denver
  • B.A., Monmouth College